Next Biomedical Co.,Ltd. Stock: price and insider trades · South Korea
넥스트바이오메디컬
No insider purchase over the last 90 days. The latest, by 남동흔, was filed 25 Jun 2026.
Who traded when
BuySaleSince the insiders bought
- -39.9%Entry ₩45,150 · Close 30 Oct 2026 ₩27,150
- +110.3%Entry ₩30,050 · Close at T+365 ₩63,200
- +63.9%Entry ₩41,300 · Close at T+365 ₩67,700
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 1,000 sharesShareKRXDART:20260625000086Canonical exit: 23 Sept 2026 (T+90)
- 2,000 sharesShareKRXDART:20260622000011Canonical exit: 20 Sept 2026 (T+90)
- 750 sharesShareKRXDART:20260526000310Canonical exit: 24 Aug 2026 (T+90)
- 1,000 sharesShareKRXDART:20260507000266Canonical exit: 30 Jul 2026 (T+90)
- ●Executives0DART
- 1,074 sharesShareKRXDART:20251203000018
- 5,600 sharesShareKRXDART:20251030000486Canonical exit: 28 Jan 2026 (T+90)
- 100,614 sharesKRXDART:20241204000221
- 410,345 sharesKRXDART:20241115000016Canonical exit: 9 Feb 2025 (T+90)
- ShareKRXDART:20241007000067Canonical exit: 25 Dec 2024 (T+90)
- ShareKRXDART:20241007000064Canonical exit: 25 Dec 2024 (T+90)
- ShareKRXDART:20241007000062Canonical exit: 25 Dec 2024 (T+90)
- ShareKRXDART:20240827000895Canonical exit: 18 Nov 2024 (T+90)
- ShareKRXDART:20240827000900Canonical exit: 18 Nov 2024 (T+90)
- 283,334 sharesKRXDART:20240826000463Canonical exit: 18 Nov 2024 (T+90)
- ShareKRXDART:20240827000884Canonical exit: 18 Nov 2024 (T+90)
- ShareKRXDART:20240827000874Canonical exit: 18 Nov 2024 (T+90)
- ShareKRXDART:20240827000856Canonical exit: 18 Nov 2024 (T+90)
- 2,578,474 sharesKRXDART:20240827000852Canonical exit: 18 Nov 2024 (T+90)
19 of 19 declarations
About Next Biomedical Co.,Ltd.
Sixteen purchases against two sales: that is the balance at 넥스트바이오메디컬 (Next Biomedical Co.,Ltd.), a South Korean health care company listed on the Korea Exchange, or 89% purchases among open-market trades. On August 20, 2024, the day of the record's first trade, 6 filers bought together. Market capitalisation is KRW 226.0 billion and insiders hold 30.1% of the capital.
In all, 19 filings come from 11 filers. 이은혜 (상무) is the most present, with 4 filings, 3 purchases and 1 sale. 한명식, 홍순석 (both 이사) and 박세환 (상무) each filed twice, all purchases.
Read moreShow less
The pace slowed after that first episode: 12 filings in 2024, 2 in 2025, then 5 in 2026. In the last twelve months, 7 filings, of which 5 purchases and 1 sale. Overall median delay: 7 days. For 15 purchases a 90-day result is stored: a median of 16.8%, with 80% of results positive, recorded past results, not a forecast.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
